US Experts Convene To Decide Whether To OK Pfizer Vaccine

A pharmacist labels syringes in a clean room where doses of COVID-19 vaccines will be handled, Wednesday, Dec. 9, 2020, at Mount Sinai Queens hospital in New York. The hospital expects to receive doses once a vaccine gets the emergency green light by U.S. regulators. (AP Photo/Mark Lennihan)

(AP) — Pfizer’s COVID-19 vaccine faces one of its final hurdles before an expected decision to greenlight the shot for use in millions of Americans. Food and Drug Administration advisers are meeting Thursday to scrutinize the company’s data for any red flags or oversights. The public review comes as U.K. regulators investigate two apparent cases of allergic reaction to the vaccine. Safety will be top of mind for the panel of medical experts, who will vote on whether to endorse the vaccine. They will also address unknowns about the vaccine’s effectiveness in certain groups. A final FDA decision and the first shots could follow within days.

Despite Fiery Crash, Landmark Test Launch Of Big Starship Prototype Deemed A Success

Previous article

Trump Announces Israel-Morocco To Normalize Relations

Next article

You may also like